| 1 | Splenic Neoplasms | 31% |
| 2 | Adenitis | 27.9% |
| 3 | Histiocytosis | 27.9% |
| 4 | Lymphadenitis | 27.9% |
| 5 | Lymphangitis | 27.9% |
| 6 | Lymphedema | 27.9% |
| 7 | Splenic Diseases | 27.9% |
| 8 | Thymus Hyperplasia | 27.9% |
| 9 | Pseudolymphoma | 27.9% |
| 10 | Lymphadenopathy | 27.9% |
| 11 | Lymphocele | 26.3% |
| 12 | Lymphangiectasis, Intestinal | 24.3% |
| 13 | Hematologic Neoplasms | 22.8% |
| 14 | Lymphoproliferative Disorders | 21.1% |
| 15 | Lymphatic Abnormalities | 21.1% |
| 16 | Abdominal Neoplasms | 20.9% |
| 17 | Head and Neck Neoplasms | 20.9% |
| 18 | Soft Tissue Neoplasms | 20.9% |
| 19 | Histiocytic Disorders, Malignant | 20.7% |
| 20 | Elephantiasis | 20.5% |
| 21 | Hypersplenism | 20.5% |
| 22 | Sarcoidosis | 20.5% |
| 23 | Elephantiasis Nostras Verrucosa | 20.5% |
| 24 | Tracheal Neoplasms | 18.9% |
| 25 | Lymphohistiocytosis, Hemophagocytic | 16.9% |
| 26 | Erdheim-Chester Disease | 16.9% |
| 27 | Agammaglobulinemia | 16.4% |
| 28 | Lymphoma | 16.4% |
| 29 | Mucocutaneous Lymph Node Syndrome | 16.4% |
| 30 | Digestive System Neoplasms | 16.4% |
| 31 | Endocrine Gland Neoplasms | 16.4% |
| 32 | Eye Neoplasms | 16.4% |
| 33 | Nervous System Neoplasms | 16.4% |
| 34 | Bone Marrow Neoplasms | 16.2% |
| 35 | Malignant histiocytosis | 16% |
| 36 | Histiocytic sarcoma | 16% |
| 37 | Bone neoplasms | 15.8% |
| 38 | Skin Neoplasms | 15.8% |
| 39 | Granuloma | 15.5% |
| 40 | Splenic Infarction | 15.5% |
| 41 | Heavy Chain Disease | 15.4% |
| 42 | Sezary Syndrome | 15.3% |
| 43 | Histiocytosis, Langerhans-Cell | 15.3% |
| 44 | Tumor Lysis Syndrome | 15.3% |
| 45 | Lung Neoplasms | 14.5% |
| 46 | Pleural Neoplasms | 14.5% |
| 47 | Parathyroid Neoplasms | 13.8% |
| 48 | Peritoneal Neoplasms | 13.8% |
| 49 | Thyroid Neoplasm | 13.8% |
| 50 | Thyroid carcinoma | 13.8% |
| 51 | Retroperitoneal Neoplasms | 13.6% |
| 52 | Infectious Mononucleosis | 13.4% |
| 53 | Waldenstrom Macroglobulinemia | 13.3% |
| 54 | Polycythemia Vera | 13.2% |
| 55 | Composite Lymphoma | 12.8% |
| 56 | Hodgkin Disease | 12.7% |
| 57 | Lymphoma, Non-Hodgkin | 12.7% |
| 58 | Sarcoidosis, Pulmonary | 12.6% |
| 59 | Acanthoma | 12.6% |
| 60 | Splenic Rupture | 12.5% |
| 61 | Paraneoplastic Encephalomyelitis | 12.5% |
| 62 | Mammary Neoplasms, Experimental | 12.2% |
| 63 | Hamartoma | 12.2% |
| 64 | Neoplasms, Hormone-Dependent | 12.2% |
| 65 | Neoplasms, Multiple Primary | 12.2% |
| 66 | Paraneoplastic Syndromes | 12.2% |
| 67 | Precancerous Conditions | 12.2% |
| 68 | Neoplasms, Second Primary | 12.2% |
| 69 | Disseminated Intravascular Coagulation | 12.2% |
| 70 | Protein S Deficiency | 12.2% |
| 71 | Leukemia, T-Cell | 11.9% |
| 72 | Leukemia, B-Cell | 11.9% |
| 73 | Thrombocythemia, Essential | 11.9% |
| 74 | Multiple Endocrine Neoplasia | 11.9% |
| 75 | Pancreatic Neoplasm | 11.9% |
| 76 | Bronchial Neoplasms | 11.9% |
| 77 | Lymphomatoid Granulomatosis | 11.7% |
| 78 | Multiple Pulmonary Nodules | 11.7% |
| 79 | Lymphangioleiomyomatosis | 11.5% |
| 80 | Lymphoma, Follicular | 10.9% |
| 81 | T-Cell Lymphoma | 10.9% |
| 82 | Mantle cell lymphoma | 10.9% |
| 83 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 10.5% |
| 84 | Leukemia, Large Granular Lymphocytic | 10.5% |
| 85 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 10.5% |
| 86 | Mouth Neoplasms | 10.3% |
| 87 | Central Nervous System Neoplasms | 10.3% |
| 88 | Vascular Neoplasms | 10.3% |
| 89 | Autoimmune Lymphoproliferative Syndrome | 10.3% |
| 90 | Genital Neoplasms, Female | 10.2% |
| 91 | Breast Neoplasms, Male | 10.1% |
| 92 | Triple Negative Breast Neoplasms | 10.1% |
| 93 | Splenosis | 10.1% |
| 94 | Esophageal Neoplasms | 10% |
| 95 | Thyroid Nodule | 10% |
| 96 | Lymphoma, T-Cell, Cutaneous | 10% |
| 97 | Lymphoma, AIDS-Related | 10% |
| 98 | Enteropathy-Associated T-Cell Lymphoma | 10% |
| 99 | Primary Effusion Lymphoma | 10% |
| 100 | Pleural Effusion, Malignant | 9.7% |
| 101 | Carcinoma, Lobular | 9.6% |
| 102 | Eosinophilic Granuloma | 9.6% |
| 103 | Mycosis Fungoides | 9.5% |
| 104 | Lymphomatoid Papulosis | 9.5% |
| 105 | Plasmablastic lymphoma | 9.5% |
| 106 | Thrombasthenia | 9.5% |
| 107 | Antithrombin III Deficiency | 9.5% |
| 108 | Protein C Deficiency | 9.5% |
| 109 | Anemia | 9.3% |
| 110 | Blood Coagulation Disorders | 9.3% |
| 111 | Blood Platelet Disorders | 9.3% |
| 112 | Bone Marrow Diseases | 9.3% |
| 113 | Hemorrhagic Disorders | 9.3% |
| 114 | Leukocyte Disorders | 9.3% |
| 115 | Methemoglobinemia | 9.3% |
| 116 | Pancytopenia | 9.3% |
| 117 | Polycythemia | 9.3% |
| 118 | Sulfhemoglobinemia | 9.3% |
| 119 | Thrombophilia | 9.3% |
| 120 | Erythrocytosis | 9.3% |
| 121 | Thrombocytosis | 9.2% |
| 122 | Cyst | 9.1% |
| 123 | Neoplastic Processes | 9.1% |
| 124 | Neoplastic Syndromes, Hereditary | 9.1% |
| 125 | Pregnancy Complications, Neoplastic | 9.1% |
| 126 | Neoplasms, Experimental | 8.9% |
| 127 | Afibrinogenemia | 8.9% |
| 128 | Factor VII Deficiency | 8.9% |
| 129 | Factor X Deficiency | 8.9% |
| 130 | Factor XII Deficiency | 8.9% |
| 131 | Hemophilia A | 8.9% |
| 132 | Activated Protein C Resistance | 8.9% |
| 133 | Factor II deficiency | 8.9% |
| 134 | Factor VIII Deficiency | 8.9% |
| 135 | Factor V deficiency | 8.9% |
| 136 | Factor XI Deficiency | 8.9% |
| 137 | Hypoprothrombinemias | 8.9% |
| 138 | Testicular Neoplasms | 8.9% |
| 139 | Meningioma | 8.6% |
| 140 | Adrenal Gland Neoplasms | 8.3% |
| 141 | Gastrointestinal Neoplasms | 8.3% |
| 142 | Genital Neoplasms, Male | 8.3% |
| 143 | Hemoglobinuria, Paroxysmal | 8.3% |
| 144 | Leukemoid Reaction | 8.3% |
| 145 | Liver neoplasms | 8.3% |
| 146 | Uveal Neoplasms | 8.3% |
| 147 | Carcinoma, Pancreatic Ductal | 8.3% |
| 148 | Urologic Neoplasms | 8.2% |
| 149 | Sebaceous Gland Neoplasms | 8.1% |
| 150 | Spinal Neoplasms | 8.1% |
| 151 | Multiple Endocrine Neoplasia Type 1 | 8.1% |
| 152 | Vitamin K Deficiency | 8% |
| 153 | Carcinoma 256, Walker | 7.7% |
| 154 | Carcinoma, Ehrlich Tumor | 7.7% |
| 155 | Dermoid Cyst | 7.7% |
| 156 | Carcinoma, Lewis Lung | 7.7% |
| 157 | Anemia, Diamond-Blackfan | 7.7% |
| 158 | Meningeal Neoplasms | 7.6% |
| 159 | Transfusion Reaction | 7.3% |
| 160 | Hypotensive Transfusion Reaction | 7.3% |
| 161 | Leukoplakia, Oral | 7.3% |
| 162 | Paraneoplastic Cerebellar Degeneration | 7.2% |
| 163 | Liver Neoplasms, Experimental | 7.2% |
| 164 | insulinoma | 7.1% |
| 165 | Burkitt Lymphoma | 7.1% |
| 166 | Neoplasms, Radiation-Induced | 7.1% |
| 167 | Vipoma | 7% |
| 168 | Gastrinoma | 7% |
| 169 | Glucagonoma | 7% |
| 170 | Pregnancy Complications, Hematologic | 7% |
| 171 | Erythroplasia | 7% |
| 172 | Follicular cyst | 7% |
| 173 | leukemia | 7% |
| 174 | Mucocele | 7% |
| 175 | Neoplasms, Germ Cell and Embryonal | 7% |
| 176 | Neoplasms, Glandular and Epithelial | 7% |
| 177 | Pilonidal Cyst | 7% |
| 178 | Thyroglossal Cyst | 7% |
| 179 | Synovial Cyst | 7% |
| 180 | Germ Cell Cancer | 7% |
| 181 | Aberrant Crypt Foci | 7% |
| 182 | Acoustic Neuroma | 6.9% |
| 183 | Purpura, Thrombotic Thrombocytopenic | 6.9% |
| 184 | Trophoblastic Neoplasms | 6.8% |
| 185 | Nose Neoplasms | 6.8% |
| 186 | Anemia, Hemolytic | 6.8% |
| 187 | Anemia, Macrocytic | 6.8% |
| 188 | Eosinophilia | 6.8% |
| 189 | Hypoproteinemia | 6.8% |
| 190 | Leukopenia | 6.8% |
| 191 | Palatal Neoplasms | 6.8% |
| 192 | Thrombocytopenia | 6.8% |
| 193 | Leukostasis | 6.8% |
| 194 | MYELODYSPLASTIC SYNDROME | 6.8% |
| 195 | Leukemia, Experimental | 6.8% |
| 196 | Neuroectodermal Tumors | 6.8% |
| 197 | Leukemia, Myelomonocytic, Chronic | 6.7% |
| 198 | Hepatocellular Adenoma | 6.7% |
| 199 | Neoplasms, Neuroepithelial | 6.7% |
| 200 | Gliomatosis cerebri | 6.7% |
| 201 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 6.7% |
| 202 | Wiskott-Aldrich Syndrome | 6.4% |
| 203 | Melanoma, Experimental | 6.4% |
| 204 | Retinoblastoma | 6.3% |
| 205 | Meningeal Carcinomatosis | 6.2% |
| 206 | Ear Neoplasms | 6.2% |
| 207 | Eyelid Neoplasms | 6.2% |
| 208 | Limbic Encephalitis | 6.2% |
| 209 | Sarcoma, Experimental | 6.1% |
| 210 | Pituitary Adenoma | 6.1% |
| 211 | Pituitary Neoplasms | 6.1% |
| 212 | Brain Neoplasms | 6% |
| 213 | Salivary Gland Neoplasms | 6% |
| 214 | Spinal Cord Neoplasms | 6% |
| 215 | Tongue Neoplasms | 6% |
| 216 | Leydig Cell Tumor | 6% |
| 217 | melanoma | 6% |
| 218 | Uterine Neoplasms | 6% |
| 219 | Vaginal Neoplasms | 6% |
| 220 | Vulvar Neoplasms | 6% |
| 221 | Uterine Cancer | 6% |
| 222 | Fallopian Tube Neoplasms | 5.9% |
| 223 | Carcinosarcoma | 5.9% |
| 224 | Hemangiosarcoma | 5.9% |
| 225 | Leukemia L1210 | 5.9% |
| 226 | Leukemia P388 | 5.9% |
| 227 | lymphangiosarcoma | 5.9% |
| 228 | Anemia, Sickle Cell | 5.8% |
| 229 | Thalassemia | 5.8% |
| 230 | Multiple Myeloma | 5.8% |
| 231 | Leukemia, Myeloid, Chronic-Phase | 5.8% |
| 232 | Nephroblastoma | 5.8% |
| 233 | ovarian neoplasm | 5.8% |
| 234 | Optic Nerve Glioma | 5.7% |
| 235 | Leukemia, Radiation-Induced | 5.7% |
| 236 | Prolactinoma | 5.7% |
| 237 | Growth Hormone-Secreting Pituitary Adenoma | 5.7% |
| 238 | Medulloblastoma | 5.6% |
| 239 | Primary Myelofibrosis | 5.6% |
| 240 | Agranulocytosis | 5.6% |
| 241 | Anemia, Megaloblastic | 5.6% |
| 242 | Lymphocytosis | 5.6% |
| 243 | Myelofibrosis | 5.6% |
| 244 | Myeloid Metaplasia | 5.6% |
| 245 | Hypoalbuminemia | 5.6% |
| 246 | Hypereosinophilic syndrome | 5.6% |
| 247 | bone marrow fibrosis | 5.6% |
| 248 | Thrombotic Microangiopathies | 5.6% |
| 249 | Tuberous Sclerosis | 5.6% |
| 250 | Cryoglobulinemia | 5.6% |
| 251 | Monoclonal Gammopathy of Undetermined Significance | 5.6% |
| 252 | Lambert-Eaton Myasthenic Syndrome | 5.5% |
| 253 | Autoimmune thrombocytopenia | 5.5% |
| 254 | Immune thrombocytopenic purpura | 5.5% |
| 255 | Sarcoma 180 | 5.4% |
| 256 | Hemangioma, Cavernous | 5.3% |
| 257 | Adenoma, Acidophil | 5.3% |
| 258 | Ganglioneuroma | 5.3% |
| 259 | Glioma | 5.3% |
| 260 | Leukoplakia | 5.3% |
| 261 | Pancreatic Cyst | 5.3% |
| 262 | Malignant Glioma | 5.3% |
| 263 | Choriocarcinoma | 5.2% |
| 264 | Pharyngeal Neoplasms | 5.2% |
| 265 | Hemolytic-Uremic Syndrome | 5.2% |
| 266 | Anemia, Neonatal | 5.2% |
| 267 | Barrett Esophagus | 5.2% |
| 268 | Breast Cyst | 5.2% |
| 269 | Actinic keratosis | 5.2% |
| 270 | Leukocytosis | 5.2% |
| 271 | Mediastinal Cyst | 5.2% |
| 272 | Neoplasm Invasiveness | 5.2% |
| 273 | Neoplasm Metastasis | 5.2% |
| 274 | Neoplasm Recurrence, Local | 5.2% |
| 275 | Paraproteinemias | 5.2% |
| 276 | Parovarian Cyst | 5.2% |
| 277 | Pelger-Huet Anomaly | 5.2% |
| 278 | Pericardial Cyst | 5.2% |
| 279 | Thymic Cyst | 5.2% |
| 280 | Pleocytosis | 5.2% |
| 281 | Carcinogenesis | 5.2% |
| 282 | Myxoid cyst | 5.2% |
| 283 | Metastasis | 5.2% |
| 284 | Central Nervous System Cysts | 5.1% |
| 285 | Sickle Cell Trait | 5.1% |
| 286 | Bile Duct Neoplasms | 5% |
| 287 | gallbladder neoplasm | 5% |
| 288 | Intestinal Neoplasms | 5% |
| 289 | Neutropenia | 5% |
| 290 | Penile Neoplasms | 5% |
| 291 | Prostatic Neoplasms | 5% |
| 292 | Stomach Neoplasms | 5% |
| 293 | Basal cell carcinoma | 5% |
| 294 | Carcinoma, Papillary | 5% |
| 295 | Squamous cell carcinoma | 5% |
| 296 | Chondrosarcoma | 5% |
| 297 | Craniopharyngioma | 5% |
| 298 | Cystadenoma | 5% |
| 299 | leiomyosarcoma | 5% |
| 300 | liposarcoma | 5% |
| 301 | Mesothelioma | 5% |
| 302 | synovial sarcoma | 5% |
| 303 | Neuroectodermal Tumor, Melanotic | 5% |
| 304 | Angiomyolipoma | 5% |
| 305 | Clear Cell Sarcoma of Soft Tissue | 5% |
| 306 | Alveolar Soft Part Sarcoma | 5% |
| 307 | Neuroendocrine Tumors | 5% |
| 308 | Sarcoma, Myeloid | 5% |
| 309 | Carcinoma, Basal Cell | 5% |
| 310 | Fanconi Anemia | 5% |
| 311 | Supratentorial Neoplasms | 5% |
| 312 | Carcinoid Tumor | 4.9% |
| 313 | Endometrial Neoplasms | 4.9% |
| 314 | Neurilemmoma | 4.9% |
| 315 | Hutchinson's Melanotic Freckle | 4.9% |
| 316 | Melanoma, Amelanotic | 4.9% |
| 317 | granulosa cell tumor | 4.9% |
| 318 | Carcinoma, Ovarian Epithelial | 4.9% |
| 319 | Opsoclonus-Myoclonus Syndrome | 4.9% |
| 320 | Atypical Hemolytic Uremic Syndrome | 4.7% |
| 321 | Febrile Neutropenia | 4.7% |
| 322 | Purpura, Hyperglobulinemic | 4.7% |
| 323 | Mesoblastic Nephroma | 4.7% |
| 324 | Adrenocortical carcinoma | 4.7% |
| 325 | Leukemia, Plasma Cell | 4.7% |
| 326 | Thrombocytopenic purpura | 4.6% |
| 327 | Astrocytoma | 4.6% |
| 328 | Ependymoma | 4.6% |
| 329 | oligodendroglioma | 4.6% |
| 330 | Ganglioglioma | 4.6% |
| 331 | gliosarcoma | 4.6% |
| 332 | Anaplastic astrocytoma | 4.6% |
| 333 | Anaplastic Oligodendroglioma | 4.6% |
| 334 | Cystadenocarcinoma | 4.6% |
| 335 | Fibrosarcoma | 4.6% |
| 336 | Osteosarcoma | 4.6% |
| 337 | Mucoepidermoid Carcinoma | 4.6% |
| 338 | Adenoma | 4.5% |
| 339 | Ameloblastoma | 4.5% |
| 340 | Angiokeratoma | 4.5% |
| 341 | Carcinoma | 4.5% |
| 342 | Chordoma | 4.5% |
| 343 | Hemangioma | 4.5% |
| 344 | hemangiopericytoma | 4.5% |
| 345 | Lymphangioma | 4.5% |
| 346 | Mesenchymoma | 4.5% |
| 347 | Nevus | 4.5% |
| 348 | Teratoma | 4.5% |
| 349 | Hepatoblastoma | 4.5% |
| 350 | Mixed Tumor, Mullerian | 4.5% |
| 351 | Germinoma | 4.5% |
| 352 | Teratocarcinoma | 4.5% |
| 353 | Angiofibroma | 4.5% |
| 354 | Sarcoma | 4.5% |
| 355 | Epithelioma | 4.5% |
| 356 | Adenomatous Polyposis Coli | 4.5% |
| 357 | Laryngeal neoplasm | 4.5% |
| 358 | Brain Stem Neoplasms | 4.4% |
| 359 | Malignant Carcinoid Syndrome | 4.4% |
| 360 | Adenofibroma | 4.3% |
| 361 | Fibroadenoma | 4.3% |
| 362 | Malignant Fibrous Histiocytoma | 4.3% |
| 363 | Myelitis, Transverse | 4.3% |
| 364 | Lymphopenia | 4.3% |
| 365 | Bladder Neoplasm | 4.3% |
| 366 | Kidney Neoplasm | 4.3% |
| 367 | Ureteral Neoplasms | 4.3% |
| 368 | Urethral Neoplasms | 4.3% |
| 369 | Glioblastoma | 4.2% |
| 370 | Neuroblastoma | 4.2% |
| 371 | Glioblastoma Multiforme | 4.2% |
| 372 | Job Syndrome | 4.2% |
| 373 | Hypopharyngeal Neoplasms | 4.2% |
| 374 | Hypopharyngeal Cancer | 4.2% |
| 375 | Hypergammaglobulinemia | 4.2% |
| 376 | Choroid Plexus Papilloma | 4.2% |
| 377 | Bowen's Disease | 4.1% |
| 378 | Paraganglioma | 4.1% |
| 379 | Rhabdomyosarcoma | 4.1% |
| 380 | Giant Cell Tumor of Bone | 4.1% |
| 381 | Parotid Neoplasms | 4.1% |
| 382 | Prostatic Neoplasms, Castration-Resistant | 4.1% |
| 383 | Nelson Syndrome | 4.1% |
| 384 | Transfusion-Related Acute Lung Injury | 4.1% |
| 385 | Corpus Luteum Cyst | 4.1% |
| 386 | Ovarian Cysts | 4.1% |
| 387 | Renal Cell Carcinoma | 4.1% |
| 388 | Ganglioneuroblastoma | 4.1% |
| 389 | Papillary Renal Cell Carcinoma | 4.1% |
| 390 | Basal Cell Nevus Syndrome | 4.1% |
| 391 | Ecchymosis | 4.1% |
| 392 | Petechiae | 4.1% |
| 393 | Purpura | 4.1% |
| 394 | Dermatofibrosarcoma | 3.9% |
| 395 | Dermatofibrosarcoma Protuberans | 3.9% |
| 396 | Hydrops Fetalis | 3.9% |
| 397 | Acute Chest Syndrome | 3.9% |
| 398 | Pulmonary Eosinophilia | 3.8% |
| 399 | Eosinophilic Pneumonia | 3.8% |
| 400 | Carcinoma, Endometrioid | 3.7% |
| 401 | Anemia, Pernicious | 3.7% |
| 402 | Pheochromocytoma | 3.7% |
| 403 | Alveolar rhabdomyosarcoma | 3.7% |
| 404 | Tonsillar Neoplasms | 3.7% |
| 405 | Cerebellar Neoplasms | 3.7% |
| 406 | Hydatidiform Mole | 3.6% |
| 407 | Niemann-Pick Disease, Type C | 3.6% |
| 408 | Endometrial Stromal Sarcoma | 3.5% |
| 409 | Nasopharyngeal carcinoma | 3.5% |
| 410 | Cecal Neoplasms | 3.5% |
| 411 | Duodenal Neoplasms | 3.5% |
| 412 | Carcinoid Heart Disease | 3.5% |
| 413 | Choledochal Cyst | 3.4% |
| 414 | Eosinophilia-Myalgia Syndrome | 3.4% |
| 415 | Pancreatic Pseudocyst | 3.4% |
| 416 | Plasmacytoma | 3.4% |
| 417 | Adenocarcinoma | 3.4% |
| 418 | Carcinoma in Situ | 3.4% |
| 419 | Carcinoma, Transitional Cell | 3.4% |
| 420 | Phyllodes Tumor | 3.4% |
| 421 | Dysgerminoma | 3.4% |
| 422 | Hemangioendothelioma | 3.4% |
| 423 | Lipoma | 3.4% |
| 424 | Myoma | 3.4% |
| 425 | Myxoma | 3.4% |
| 426 | Neuroma | 3.4% |
| 427 | Papilloma | 3.4% |
| 428 | Pseudomyxoma Peritonei | 3.4% |
| 429 | Seminoma | 3.4% |
| 430 | Papillomatosis | 3.4% |
| 431 | Angiolipoma | 3.4% |
| 432 | Myelolipoma | 3.4% |
| 433 | Neoplasms, Bone Tissue | 3.4% |
| 434 | Neoplasms, Fibrous Tissue | 3.4% |
| 435 | Smooth Muscle Tumor | 3.4% |
| 436 | Adenomatosis, Pulmonary | 3.4% |
| 437 | Adenomatous Polyps | 3.4% |
| 438 | Carcinoma, Large Cell | 3.4% |
| 439 | Carcinoma, Small Cell | 3.4% |
| 440 | Desmoplastic Small Round Cell Tumor | 3.4% |
| 441 | Chondroma | 3.4% |
| 442 | Enchondroma | 3.4% |
| 443 | Lymphatic Metastasis | 3.4% |
| 444 | Neoplasms, Unknown Primary | 3.4% |
| 445 | Leukemic Infiltration | 3.4% |
| 446 | Neoplasm Micrometastasis | 3.4% |
| 447 | Peutz-Jeghers Syndrome | 3.4% |
| 448 | Neurofibrosarcoma | 3.4% |
| 449 | Chronic granulomatous disease | 3.4% |
| 450 | Shwartzman Phenomenon | 3.4% |
| 451 | Scurvy | 3.3% |
| 452 | Purpura Fulminans | 3.3% |
| 453 | Waterhouse-Friderichsen Syndrome | 3.3% |
| 454 | Denys-Drash Syndrome | 3.2% |
| 455 | Nasopharyngeal Neoplasms | 3.1% |
| 456 | Appendiceal Neoplasms | 3.1% |
| 457 | Colonic Neoplasms | 3.1% |
| 458 | Rectal Neoplasms | 3.1% |
| 459 | Colorectal Neoplasms | 3.1% |
| 460 | Adenoid Cystic Carcinoma | 2.8% |
| 461 | fibroma | 2.8% |
| 462 | Fibromatosis | 2.8% |
| 463 | Osteoblastoma | 2.8% |
| 464 | Osteoma | 2.8% |
| 465 | Rhabdomyoma | 2.8% |
| 466 | Chondromatosis | 2.8% |
| 467 | Adenocarcinoma, Clear Cell | 2.8% |
| 468 | Cholangiocarcinoma | 2.8% |
| 469 | Cervical Intraepithelial Neoplasia | 2.8% |
| 470 | Hemangioblastoma | 2.8% |
| 471 | Lymphoma, Extranodal NK-T-Cell | 2.8% |
| 472 | Paranasal Sinus Neoplasms | 2.8% |
| 473 | POEMS Syndrome | 2.8% |
| 474 | Thymoma | 2.7% |
| 475 | Polycystic Ovary Syndrome | 2.7% |
| 476 | Anus Neoplasms | 2.6% |
| 477 | Sigmoid Neoplasms | 2.6% |
| 478 | Kernicterus | 2.5% |
| 479 | Fibromatosis, Aggressive | 2.5% |
| 480 | Fibromatosis, Abdominal | 2.5% |
| 481 | Klatskin Tumor | 2.5% |
| 482 | Maxillary Sinus Neoplasms | 2.4% |
| 483 | Primary amyloidosis | 2.2% |
| 484 | Mastocytoma | 2.1% |
| 485 | Mastocytosis, Systemic | 2.1% |
| 486 | Mastocytosis | 2% |
| 487 | Sturge-Weber Syndrome | 2% |
| 488 | Xeroderma Pigmentosum | 2% |
| 489 | Cell Transformation, Viral | 2% |
| 490 | Gastrointestinal Stromal Tumors | 2% |
| 491 | neurofibroma | 2% |
| 492 | Pseudoxanthoma Elasticum | 1.9% |
| 493 | Dupuytren Contracture | 1.5% |
| 494 | Urticaria Pigmentosa | 1.5% |
| 495 | Zollinger-Ellison syndrome | 1.5% |
| 496 | Radicular Cyst | 1.1% |